Human proof for vasoactive intestinal peptide spans respiratory failure trials, chronic lung disease studies, CIRS cohorts, and observational biomarker data — a broader medical evidence base than most peptides in existing analysis.Your individual info will likely be used to help your knowledge during this website, to manage access to your account